Biotech: Page 51
-
PharmaVoice Team/PharmaVoice
The Researchers
Julian Adams, Ph.D. Alain D. Baron, M.D. Martine Clozel, M.D. Jean-Jacques Garaud, M.D. Amir H. Kalali, M.D. Dennis Keith, Ph.D. Nick Kenny, Ph.D. Geert J.C.M. Kolvenbag M.D., Ph.D., F.F.P.M Evan Loh, M.D. Karen Seibert, Ph.D. The Researchers PRODUCTS BECOME BRANDS BECAUSE OF THE DEDICATION AND P...
By PharmaVoice Team • July 24, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Operations: Bringing All of the Pieces Together
6 June 20 08 VIEW on Clinical Operations THE FORUM A recentTufts CSDD study cites research showing that the cost to develop a new biopharmaceutical is now more than $1 billion. Accordingly, clinical organizations are under growing pressure to reduce research and development costs while accelerati...
By PharmaVoice Team • June 9, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
DIA Preview Showcase
SPECIAL FEATURE DIA 44TH ANNUAL MEETING Representing more than 20,000 members worldwide involved in discovery, development, regulation, and marketing of bio/phar maceutical and related products, the Drug Information Association (DIA) each year has the significant task of designing an annual meeti...
By PharmaVoice Team • May 28, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
THE OTC MARKET Plop,Plop, Fizz, Fizz Consumers are taking an increasingly active role in self medication because of rising healthcare costs, a large uninsured population, and ever more choices in OTC products. Purchasing OTC drugs also is more convenient and money is saved avoiding doctor’s visit...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
Raise your voice: Letters
Digital Training With the emergence of digital technology as the fastest growing means of delivering brand marketing and messaging, digital training is one of the best investments agencies can make to address the increasing pressures and speed of change cited by so many of your experts in the Apr...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
Special Feature: HBA's 2008 Rising Stars
BY TAREN GROM Nelson. CommonHealth. There is no magic formula, no set of qualities or attributes which when combined in exact pro portions spontaneously produces a leader. Cer tainly many leaders possess similar characteris tics — innovation, persuasion, charisma, etc. — but what sets a leader ap...
By Taren Grom • April 30, 2008 -
PharmaVoice Team/PharmaVoice
Seeding Early-Stage Research
Future success in the pharmaceutical industry will hinge on the ability of companies to deliver novel products that meet patient needs. To do that, pharma companies are teaming up with biotech companies, launching their own biotech divisions, investing in genetics, and acquiring other companies, ...
By Denise Myshko • April 30, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Michael V. Novinski became President and CEO of Emisphere Technologies in May 2007. Previously, he served as President of Organon USA with additional responsibility for worldwide business development and lifecycle management.While serving as Organon’s Director of Marketing and later as VP of Mark...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
ONTHE CALENDAR May 1516 13th Annual Pharmaceutical &Biotech Licensing &Deal Making Summit Hyatt Regency NewBrunswick,New Brunswick,N.J. For more information, contact Cheryl KahanRadhuber,Strategic Research Institute, at 2129670095, email [email protected], or visit srinstitut...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Immune Tolerance Institute (ITI), a new nonprofit company, is bringing economies of scale to translational and critical path science to build partnerships with the pharmaceutical and biotech industries, and accelerate the development of new ...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Pharma POOL John I. COOPER Former GlaxoSmithKline VP Brings Global Manufacturing and Operational Management Expertise to ICN ICN Pharmaceuticals Inc. has appointed John I. Cooper as executive VP of global manufacturing and supply. I...
By PharmaVoice Team • April 22, 2008 -
PharmaVoice Team/PharmaVoice
Regulatory Submissions: Improving the Process
BY TAREN GROM IMPROVING E-STRATEGIES The inability to effectively manage complex submission documentation for new drug applications (NDAs) and other regulated dossiers is a major factor in slowing the time it takes to bring a product to market. These delays cost the lifescience industry millions ...
By PharmaVoice Team • April 21, 2008 -
PharmaVoice Team/PharmaVoice
Alan Holmer — The Industry's Champion
THE INDUSTRY’S CHAMPION BY KIM RIBBINK After a weighty career in politics and the law, and now seven years into his leadership position at the Pharmaceutical Research and Manufacturers of America, Alan F. Holmer is positioning the organization to address criticisms of the industry and convey to t...
By PharmaVoice Team • April 21, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-MEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES SoftWatch and InfoMedics DELIVER INTEGRATED MARKETING SOLUTION SoftWatch Inc.and InfoMedics Inc.have launched a joint solution for optimizing patient-fulfillment programs executed simultaneously across multiple communica...
By PharmaVoice Team • April 21, 2008 -
PharmaVoice Team/PharmaVoice
Learning to Work With E-Learning
Learning to work with BY ELISABETH PENA As technology continues to make highspeed communication a reality, the industry is beginning to take advantage of these tools to teach and train. Using the Internet in combination with traditional teaching principles, companies can span great distances and ...
By PharmaVoice Team • April 17, 2008 -
PharmaVoice Team/PharmaVoice
Spiros Jamas — A Chemical Reaction
DR.SPIROS JAMAS is leading Enanta Pharmaceuticals by tapping the company’s primary strength in its integration of chemistry and biology to tackle new targets and specific drugdevelopment challenges from all possible angles right from the start. He is relying on the hardwon lessons learned from hi...
By Kim Ribbink • April 17, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Anne NOBLES Dr.Thomas VERHOEVEN Lilly Announces Personnel Changes Eli Lilly, Indianapolis, has promoted Anne Nobles to VP of corporate affairs from Strattera product team leader. Ms. Nobles has replaced Deborah Steelman, who resigned for personal reasons. In her new role, she leads go...
By PharmaVoice Team • April 17, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
58 A ug u s t 20 03 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES EDocCompliance for the Oracle platform, recently launched by Qumas, is a readytovalidate, Web based application that manages the full life cycle of regulatorycontrolled documentation without t...
By PharmaVoice Team • April 17, 2008 -
PharmaVoice Team/PharmaVoice
Biotech Life-Cycle Management
10 J u n e 20 03 PharmaVOICE THE MANAGEMENTTEAM … CAROLCHERKIS,PH.D. Life sciences consultant,NewCap Partners Inc., Los Angeles; NewCap Partners is a private investment banking firm that focuses on the finance needs of middlemarket companies.For more information, visit newcap.com. TILLMAN U.GERNG...
By PharmaVoice Team • April 17, 2008 -
PharmaVoice Team/PharmaVoice
The Emergence of the Bioscience Cluster
36 J un e 2 003 PharmaVOICE ll drug development is local, to borrow from a popular phrase. Although pharma and biotech companies have to be focused on global issues, they still are firmly rooted in the commu nities in which they reside. State and local governments recognize the benefits to the lo...
By PharmaVoice Team • April 16, 2008 -
PharmaVoice Team/PharmaVoice
Striking a Balance for Innovation
26 J u n e 20 03 PharmaVOICE INNOVATION Striking a Balance for BY DENISE MYSHKO Recently proposed regulations strive to restore the balance between protecting the intellectual assets related to innovation by pharmaceutical manufacturers and the opportunity to bring lowercost generic products to m...
By PharmaVoice Team • April 16, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
3 PharmaVOICE J un e 2003 PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Vo...
By Taren Grom • April 16, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
60 J u l y 20 03 PharmaVOICE Pharma POOL Lynn BAER Dr. Manny BORREGO Novo Nordisk Announces Two Key Appointments for U.S. Medical Department Novo Nordisk, a focused healthcare compa ny and leader in diabetes care, with U.S. headquar ters in Princeton, N.J., has promoted Lynn Baer to senior direct...
By PharmaVoice Team • April 10, 2008 -
PharmaVoice Team/PharmaVoice
A View on Advertising — A Shifting Landscape
6 Ma r ch 20 08 VIEW on Advertising THE FORUM The advertising focus may be moving away from center — traditional media such as television and print — as emerging media, such as Web 2.0, and alternative vehicles such as Pod casts, search engines, etc., begin to establish a firmer foothold in the m...
By PharmaVoice Team • March 24, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
76 S e p t e m b e r 200 3 PharmaVOICE Johnson & Johnson is TOP PHARMA COMPANY IN LONGTERM CARE Johnson & Johnson has been selected as the best overall pharmaceutical company by longte rm care (LTC) pharmacists participating in Verispan’s spring 2003 Nursing Home PharmacyProvider/Con sult...
By PharmaVoice Team • March 19, 2008
Previous
